إسرائيل - العبرية - Ministry of Health

novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 80 mg; hydrochlorothiazide 12.5 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension for patients in whom combination therapy is appropriate.

إسرائيل - العبرية - Ministry of Health

novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 160 mg; hydrochlorothiazide 12.5 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.

إسرائيل - العبرية - Ministry of Health

novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 160 mg; hydrochlorothiazide 25 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.

إسرائيل - العبرية - Ministry of Health

ami technologies ltd., israel - peflurten - תרחיף להזרקה - peflurten 1.1 mg/ml - other cardiovascular system diagnostic radiopharmaceuticals - echocardiography: definity (perflutren injectable suspension) is indicated for contrast-enhanced ultrasound imaging of cardiac structures (ventricular chambers and endocardial borders) and function (regional wall motion) in adult patients with suboptimal echocardiograms. abdominal ultrasound : definity is also indicated for contrast-enhanced ultrasound imaging of the liver and kidneys in adult patients to improve the evaluation of pathology.

إسرائيل - العبرية - Ministry of Health

perrigo israel agencies ltd - milnacipran hydrochloride - קפסולות - milnacipran hydrochloride 25 mg - milnacipran - milnacipran - treatment of major (i.e. all characteristics) depressive episodes in adults over 18 years old.

إسرائيل - العبرية - Ministry of Health

dexcel ltd, israel - gadobenic acid as dimeglumine salt - תמיסה להזרקה - gadobenic acid as dimeglumine salt 334 mg/ml - gadobenic acid - gadobenic acid - multihance is a paramagnetic contrast agent for use in diagnostic magnetic resonance imaging (mri) indicated for: • mri of the liver for the detection of focal liver lesions in patients with known or suspected primary liver cancer (eg. hepatocellular carcinoma) or metastatic disease.• mri of the brain and spine where it improves the detection of lesions and provides diagnostic information additional to that obtained with unenhanced mri.• contrast-enhanced mr- angiography where it improves the diagnostic accuracy for detecting clinically significant steno-occlusive vascular disease in patients with suspected or known vascular disease of the abdominal or peripheral arteries.

إسرائيل - العبرية - Ministry of Health

dexcel pharma technologies ltd - tramadol hydrochloride - טבליות בשחרור ממושך - tramadol hydrochloride 100 mg - tramadol - tramadol - treatment of moderate to severe pain.

إسرائيل - العبرية - Ministry of Health

dexcel pharma technologies ltd - tramadol hydrochloride - טבליות בשחרור ממושך - tramadol hydrochloride 200 mg - tramadol - tramadol - treatment of moderate to severe pain.

إسرائيل - العبرية - Ministry of Health

dexcel pharma technologies ltd - tramadol hydrochloride - טבליות בשחרור ממושך - tramadol hydrochloride 300 mg - tramadol - tramadol - treatment of moderate to severe pain.

إسرائيل - العبرية - Ministry of Health

promedico ltd - barium sulfate - אבקה להכנת תרחיף - barium sulfate 96.476 %w/w - barium sulfate without suspending agents - barium sulfate without suspending agents - for rectal administration (enema) as a radio-opaque agent for x-ray visualisation of the lower gastro-intestinal tract. it is designed for both single contrast barium enema and air-double contrast enema usage.